Multivariate analysis of prognostic factors in 106 patients with malignant glioma

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1918-1923

  Salminen, E ^a   Nuutinen, J M ^b   Huhtala, S ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Turku University   (Finland)

Author keywords

Malignant glioma; Prognostic factors; Radiotherapy; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GLIOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0030271752     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00211-0     Document Type: Article

References (31)

1. 1. Ahlbom A, Rodvall Y. Brain tumour trends. Lancet 1989, 2, 1272.
2. 2. Cancer Society of Finland, Publication No. 54. Cancer Incidence in Finland 1992, Helsinki 1994.
3. 3. Walker M, Green S, Byar D, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Eng J Med 1980, 303, 1323-1329.
4. 4. Halperin E, Burger P, Bullard D. The fallacy of localized supratentorial malignant glioma. Int J Rad Oncol Biol Phys 1988, 15, 505-509.
5. 5. Nelson D, Curran W, Scott C, et al. Hyperfractionated radiation therapy and bis-chlorethylnitrosourea in the treatment of malignant glioma. Int J Rad Oncol Biol Phys 1993, 25, 193-207.
6. 6. Gonzales D, Menten J, Bosch D, van der Schueren E, Troost D, Hulshof M, Bernier J. Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol 1994, 32, 98-105.
7. 7. Salazar O, Rubin P, Feldstein M, Pizzutiello R. High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Rad Oncol Biol Phys 1979, 5, 1733-1740.
8. 8. Färkkilä M. Symptoms, diagnostics and treatment organization in brain tumours. Finnish Med J 1994, 32, 3297-3300.
9. 9. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
10. 10. Zulch K. Histological typing of tumours of the central nervous system. International histological classification of tumours. World Health Organization, Geneva 1979, No. 21.
11. 11. Hakulinen T, Pukkala E, Hakama M, et al. Survival of cancer patients in Finland in 1953-1974. Ann Clin Res 1981, 13(s), 13.
12. 12. Shugg D, Allen B, Blizzard L, Dwyer T. Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer 1994, 59, 765-770.
13. 13. Giles G, McNeil J, Donnan G, et al. Dietary factors and the risk of glioma in adults: results of a case-control study in Melbourne, Australia. Int J Cancer 1994, 59, 357-362.
14. 14. Boyle P, Maisonneuve R, Muir C. Is the increased incidence of primary brain tumours in the elderly real? J Natl Cancer Inst 1990, 82, 1594-1596.
15. 15. Greig N, Ries L, Yancik R, Rapoport S. Increasing annual incidence of primary malignant brain tumours in the elderly. J Natl Cancer Inst 1990, 82, 1621-1624.
16. 16. Davis L, Ahlbom A, Hohl D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991, 19, 423-431.
17. 17. Helseth A, Langmark F, Mork S. Neoplasms of the central nervous system in Norway. Acta Pathol Microbiol Immunol Scand 1988, 96, 1066-1074.
18. 18. Seither R, Jose M, Paris K, Lindberg R, Spanos W. Results of irradiation in patients with high grade gliomas evaluated by magnetic resonance imaging. Am J Clin Oncol 1995, 18, 297-299.
19. 19. Walker M, Alexander E, Hunt W, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978, 49, 333-343.
20. 20. Kristiansen M, Hagen S, Kollevold T, et al. Combined modality therapy of astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time. Cancer 1981, 47, 649-652.
21. 21. Marcial-Vega V, Wharam M, Leibel S, Clark A, Zweig R, Order S. Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy. Int J Rad Oncol Biol Phys 1986, 16, 1419-1434.
22. 22. Goodman G, Skarsgard L, Thompson G, Harrison R, Lam G, Lugate C. Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4; a pilot study. Radiother Oncol 1990, 17, 21-28.
23. 23. Gaspar L, Fisher B, Macdonald D, et al. Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Rad Oncol Biol Phys 1992, 24, 55-57.
24. 24. Thomas R, James N, Guerrero D, Ashley S, Gregor A, Brada M. Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 1994, 33, 113-116.
25. 25. Prados M, Wara W, Edwards M, et al. The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Rad Oncol Biol Phys 1995, 32, 85-91.
26. 26. Bleehen N, Stenning S. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 1991, 64, 769-774.
27. 27. Fine H, Dear K, Loeffler J, Black P, Canellos G. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993, 71, 2585-2587.
28. 28. Ganju V, Jenkins R, O'Fallon J, et al. Prognostic factors in gliomas. Cancer 1994, 74, 920-927.
29. 29. Chang C, Horton J, Schoenfeld D, et al. Comparison of post-operative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983, 52, 997-1007.
30. 30. Florell R, MacDonald D, Irish W, et al. Selection bias, survival and brachytherapy for glioma. J Neurosurg 1992, 76, 179-183.
31. 31. Laramore G, Martz K, Nelson J, Griffin T, Chang C, Horton J. Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more agressive form of treatment adversely impact survival? Int J Rad Oncol Biol Phys 1989, 17, 1351-1356.